Home/Filings/4/0000950170-25-009793
4//SEC Filing

Fox Christine Ann 4

Accession 0000950170-25-009793

CIK 0001719714other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 4:05 PM ET

Size

5.7 KB

Accession

0000950170-25-009793

Insider Transaction Report

Form 4
Period: 2025-01-25
Fox Christine Ann
Chief Financial Officer
Transactions
  • Award

    Share Options (Right to buy)

    2025-01-25+262,000262,000 total
    Exercise: $2.91Exp: 2035-01-25American Depository Shares (262,000 underlying)
Footnotes (2)
  • [F1]25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter.
  • [F2]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Documents

1 file

Issuer

Mereo BioPharma Group plc

CIK 0001719714

Entity typeother

Related Parties

1
  • filerCIK 0002005755

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:05 PM ET
Size
5.7 KB